期刊文献+

三维适形放疗联合小剂量顺铂治疗老年非小细胞肺癌的疗效观察 被引量:7

Three Dimensional-conformal Radiotherapy Combined with Low-dose Cisplatin in Treatment of Elderly Non-small Cell Lung Cancer
下载PDF
导出
摘要 目的观察三维适形放疗联合小剂量顺铂治疗老年非小细胞肺癌(NSCLC)的疗效和不良反应。方法回顾性分析36例年龄≥75岁的老年非小细胞肺癌患者在接受三维适形放疗50~60 Gy,同步静脉应用顺铂40 mg,1次/周至放疗结束,放化疗结束两周后的疗效及不良反应。结果 36例患者中完全缓解(CR)7例,部分缓解(PR)19例,稳定(SD)6例,进展(PD)4例,总有效率(CR+PR)为72.2%,临床获益率(CR+PR+SD)为88.9%。放射性食管炎、轻度胃肠道反应和Ⅰ~Ⅱ度骨髓抑制是主要的不良反应。结论三维适形放疗联合小剂量顺铂治疗年龄≥75岁的老年非小细胞肺癌疗效较好,不良反应轻,耐受性好,值得临床广泛应用。 Objective To investigate the effect and toxicity of treatment with three dimensional-conformal radiotherapy and low dose Cisplatin on the elderly patients with non-small cell lung cancer (NSCLC). Methods To retrospectively analyze the effect and toxicity of 36 elderly NSCLC patients with aging greater or equal to 75 ,all the patients were given 3DCRT with 50-60 Gy and paclitaxe Cisplatin chemotherapy. Results CR was achieved in 7 cases,PR in 19 cases,SD in 6 eases,PD in 4 cases,the overall response rate (CR+ PR) was 72.2% and the clinical benefit rate (CR+ PR+ SD) was 88.90/oo. The important adverse effects were radiation esophagitis,gastrointestinal toxicity and bonemarrow suppression. Conclusion Three dimensional-conformal radiotherapy combined with low-dose cisplatin for elderly patients with non smalI cell lung cancer was safe and effective,the toxicity was tolerable.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2012年第1期85-87,共3页 Cancer Research on Prevention and Treatment
关键词 三维适形放疗 顺铂 非小细胞肺癌 Three dimensional-conformal radiotherapy Cisplatin NSCLC
  • 相关文献

参考文献7

二级参考文献11

  • 1王燕,张湘茹.老年晚期肺癌的治疗策略[J].癌症进展,2004,2(6):490-492. 被引量:47
  • 2[1]Non-small Cell Lung Cancer Co-operative.Chemotherapy in non-small cell lung cancer:a meta-analysis using up-dated data on individual patients from 52 randomized trials.Br MedJ,1995(31):899-909.
  • 3[2]Sorenson S,GlimeliusB,Nygren P.A systematic overview of chemotherapy effects in non-small cell lung cancer.ActaOncol,2001,40(2-3):327-339.
  • 4[3]Shord SS,Faucette SR,Gillenwater HH,et al.Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer.Cancer Chemother Pharmacol,2003,51(4):328-336.
  • 5[4]Inoue A,Saijo N.Recent advances in the chemotherapy of non-small cell lung cancer.Jpn J Clin Oncol,2001,31(7):299-304.
  • 6Eisert DR, Cox JD, Komaki R. Irradiation for bronchial carcinoma : reason for failure. Ⅲ. Analysis of local control as a function of dose, time, and fractionation[ J ]. Cancer, 1976, 37 (6) :2665 - 2670.
  • 7Rosenweig KE,Sin S ,Mychaczak B ,et al. Elective nodal irradiation in treatment of non - small cell lung cancer with three -dimensional conformal radiation therapy(3CRT) [ J]. Int J Radiat Oncol Biol Phys,1999,45( 1 suppl 3) :243 -244.
  • 8C. Manegold,U. Gatzemeier,J. von Pawel,R. Pirker,R. Malayeri,J. Blatter,K. Krejcy. Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, Pemetrexed disodium, ALIMTATM) and cisplatin: A multicenter phase II trial[J] 2000,Annals of Oncology(4):435~440
  • 9宋启斌,胡德胜,徐利明,李长青.三维适形放射治疗配合化疗治疗局部晚期非小细胞肺癌[J].中华放射肿瘤学杂志,2002,11(3):174-176. 被引量:50
  • 10吴开良,蒋国梁,王鹏,周莉均.肺癌三维适形放射治疗靶体积确定的影响因素[J].中华放射肿瘤学杂志,2003,12(3):188-191. 被引量:36

共引文献10

同被引文献64

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部